Arvind Govindarajan assumes the role of Chief Technology Officer, tasked with overseeing the architecture and Agentic AI roadmap for AuraTrace, the firm's flagship SaaS offering. His mandate includes ensuring the platform remains compliant with the rigorous regulatory demands governing pharmaceutical and clinical research organizations. Krystal Kermott joins as Vice President and Head of Business Development, focusing on commercial growth and the integration of the company’s services into the broader life sciences ecosystem.

CEO Vikas Agarwal emphasized that the industry currently suffers from disconnected systems that hinder visibility between procurement and quality oversight. By unifying these functions, the company intends to provide audit-ready transparency that allows teams to understand the cross-functional impacts of their decisions. The newly secured capital will accelerate product development, expand consulting capabilities, and broaden the company's commercial reach as it scales its operations.